SOP for EU IMP/Device Labelling (Annex 13/Annex VI) Specifics
SOP for EU IMP/Device Labelling (Annex 13/Annex VI) Specifics { “@context”: “https://schema.org”, “@type”: “Article”, “mainEntityOfPage”: { “@type”: “WebPage”, “@id”: “https://www.clinicalstudies.in/sop-for-eu-imp-device-labelling-annex-13-annex-vi-specifics” }, “headline”: “SOP for EU IMP/Device Labelling (Annex 13/Annex VI) Specifics”, “description”: “This SOP outlines EU-specific labelling requirements for Investigational Medicinal Products (IMPs) and devices under Annex 13 and Annex VI. It ensures compliance with…
Read More “SOP for EU IMP/Device Labelling (Annex 13/Annex VI) Specifics” »